Page last updated: 2024-10-31

mirtazapine and Morbid Obesity

mirtazapine has been researched along with Morbid Obesity in 2 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research Excerpts

ExcerptRelevanceReference
"Mirtazapine is a noradrenergic and specific serotonergic antidepressant, which blocks the 5HT3 receptor, leading to an antiemetic effect."1.33Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass. ( Breda, MF; Novaretti, TM; Pereira, PG; Pilon, B; Teixeira, FV, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teixeira, FV1
Novaretti, TM1
Pilon, B1
Pereira, PG1
Breda, MF1
Huerta, S1
Siddiqui, A1

Other Studies

2 other studies available for mirtazapine and Morbid Obesity

ArticleYear
Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass.
    Obesity surgery, 2005, Volume: 15, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Female; Gastric Bypass; Humans; Mianserin; Mirtazapine; Obesity

2005
Intractable nausea and vomiting following Roux-en-Y gastric bypass: role of mirtazapine.
    Obesity surgery, 2006, Volume: 16, Issue:10

    Topics: Adult; Antiemetics; Female; Gastric Bypass; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine

2006